피엔케이피부임상연구센타

347740KOSDAQ그외 기타 전문, 과학 및 기술 서비스업

73.1 / 100

Reference Date: 2026-04-13

Financial Score38.0 / 40

News Sentiment19.1 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PNK 피부임상연구센타 conducts human trials and in-vitro tests to verify the safety and efficacy of cosmetics, health functional foods, and beauty devices. The company's main revenue comes from cosmetic human trials (90.98%), while also offering testing services for health foods and beauty devices.

Number of Employees

121people

Average Salary

43.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.58Industry Average 59.138.0Point

Half of industry avg (excellent)

PBR

0.82Industry Average 1.947.0Point

Half of industry avg (excellent)

ROE

5.85Industry Average 1.537.0Point

3.8x industry avg (excellent)

Debt Ratio

1.24Industry Average 16.098.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲23.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲69.9% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.6% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
P&K, 디알리서치와 임상연구 협력 전략적 MOU
피엔케이피부임상연구센타는 디알리서치와 피부·화장품·건강기능식품·웰니스 분야 임상연구 협력을 위한 전략적 업무협약(MOU)을 체결했습니다.
Positive
"임상연구·검체분석 통합 솔루션" 피엔케이, 디알리서치와 '맞손'
피엔케이피부임상연구센타는 디알리서치와의 협력을 통해 임상연구 및 맞춤형 검체분석 통합 솔루션을 제공하며 건기식·디지털 헬스 분야로 협력을 확대하여 중장기 성장 기반을 강화하고 있습니다.
Positive
"뷰티 테크 고도화 가속" 이해광 P&K 대표, 'KIMES' 발표
피엔케이피부임상연구센타는 피부 노화지수 빅데이터 기반 개인화 뷰티 기술을 선보이며 뷰티 테크 고도화를 가속화하고 있으며, KIMES 2026에서 기술 방향성과 사업 확장 가능성을 제시했습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (16%, downtrend)

Current 2,200Won52-week high 3,23552-week low 1,996

1-month return3.0Point

1m 0.92% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0

Neutral기업가치제고계획(자율공시)2026-04-01
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral정기주주총회결과2026-03-31
Neutral사업보고서 (2025.12)2026-03-23
Neutral감사보고서제출2026-03-23